AskVantage

Haku Bio

Haku Bio is a startup headquartered in Arlington, United States, founded in 2026. It has raised at least $1.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2026Founded
StartupStage
Arlington, United StatesHeadquarters
BiotechnologyIndustry
$1.5m+Raised (SEC filings)
SeedFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Haku Bio has raised at least $1.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Haku Bio sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.

Other startups in Arlington

Related

Questions and answers

What does Haku Bio do?

Haku Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Haku Bio raised?

At least $1.5m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Haku Bio based?

Haku Bio is headquartered in Arlington, United States.

When was Haku Bio founded?

Haku Bio was founded in 2026.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.